• Membership
  • Advert Rates
  • Careers
  • About Us
  • Contact Us
  • Digital Store
Wednesday, June 25, 2025
The Trumpet Newspaper Nigeria
No Result
View All Result
  • Home
  • News
    • Breaking News
    • Headlines
    • Metro
    • Health
  • Politics
  • Business
    • Ecommerce
    • Economy
    • Start-up
  • Entertainment
  • Sports
  • Opinion
    • Religion
    • Columnists
    • Contributors
    • Editorial
  • Global
    • Climate
    • Culture
    • Tourism
    • Technology
    • Weather
    • Social Media
  • e-Edition
  • Home
  • News
    • Breaking News
    • Headlines
    • Metro
    • Health
  • Politics
  • Business
    • Ecommerce
    • Economy
    • Start-up
  • Entertainment
  • Sports
  • Opinion
    • Religion
    • Columnists
    • Contributors
    • Editorial
  • Global
    • Climate
    • Culture
    • Tourism
    • Technology
    • Weather
    • Social Media
  • e-Edition
No Result
View All Result
The Trumpet Newspaper Nigeria
No Result
View All Result
ADVERTISEMENT
Home Health

US: In Reversal, FDA Puts Brakes on Covid Shots for Kids Under 5

Sharon O. Isaalah by Sharon O. Isaalah
February 6, 2025
in Health
Reading Time: 4 mins read
0
US: In Reversal, FDA Puts Brakes on Covid Shots for Kids Under 5
0
SHARES
0
VIEWS
Share on FacebookShare on TwitterShare on LinkedinShare on WhatsAppShare on Pinterest

COVID-19 vaccinations for children under 5 hit another monthslong delay Friday as U.S. regulators abruptly put the brakes on their efforts to speed review of the shots that Pfizer is testing for youngsters.

The Food and Drug Administration, worried about the omicron variant’s toll on kids, had taken the extraordinary step of urging Pfizer to apply for the OK of the extra-low dose vaccine before it’s clear if tots will need two shots or three. The agency’s plan could have allowed vaccinations to begin within weeks.

ADVERTISEMENT

But Friday, the FDA reversed course and said it had become clear the agency needed to wait for data on how well a third shot works for the youngest age group. Pfizer said in a statement that it expected the data by early April.

FDA’s vaccine chief Dr. Peter Marks said he hoped parents would understand that the agency’s decision was part of its careful scientific review of the evidence Pfizer has submitted so far.

That information “made us realize that we needed to see data from a third dose from the ongoing trial in order to make a determination,” Marks told reporters. “We take our responsibility for reviewing these vaccines very seriously because we’re parents as well.”

The nation’s 18 million children under 5 make up the only age group not yet eligible for vaccination.

Rachel Perera, the mother of an 8-month-old from Los Angeles, said Friday’s news felt “like the rug just got pulled out from under me.”

After consulting with her pediatrician, Perera hoped a vaccine would be available this winter, or in early 2022 at the latest. The education policy researcher and her husband are caring for their child to avoid the unpredictability and risks of child care during a pandemic. But that means working on her dissertation for the Ph. D. She is pursuing it when her child sleeps. On top of that, the daily calculations of risks, she says, have left her with “decision fatigue.”

“I’m just tired, and it feels like ‘when is this going to end’?” Perera said. “It feels like people around us are moving on with their lives, and we’re being left behind.”

Vaccine experts had been concerned with the sudden race to evaluate Pfizer’s vaccine — and now wonder what parents will make of the back-and-forth.

“I think they made the right decision to be careful and wait for the third-dose data,” said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief.

“It was great to hear that there might be some promising data from two doses but it came out as ‘Hey everybody, you can expect a vaccine in a few weeks,'” he added. “I think this messaging gets very confusing for people.”

It’s not the first delay. Pfizer originally had expected to know by late December if the extra-low doses worked for kids under 5 — only to face a disappointing setback. Preliminary study results showed two shots were safe and strong enough to give good protection to babies as young as 6 months. But once tots reached preschool age — the 2- to 4-year-olds — two doses weren’t protective enough, prompting the addition of a third to the study.

So it was a surprise when a few weeks ago, the FDA urged Pfizer and its partner BioNTech to go ahead and apply. Next week, the agency’s independent scientific advisers were set to publicly debate if it was OK to start giving tots two shots before there was proof that a third would give them the extra needed protection — a highly unusual move.

Read Also: Beijing: Britain’s Dave Ryding Presumptuous to Win a Medal in Winter Olympics

Friday, the FDA abruptly canceled that meeting, promising to hold it once Pfizer submits the third-dose evidence. Even if Pfizer completes its submission by early April, it will take the FDA and other health authorities several weeks to review and publicly vet the data.

Earlier this week, FDA’s Marks had promised the agency wouldn’t cut corners but also noted how rapidly the pandemic was changing. Before Thanksgiving, no one had heard of omicron, by last month pediatric COVID-19 infections had hit an all-time high — and now cases are dropping fast as the latest mutant burns out.

How long to wait for new vaccine data — and how much to require — is a difficult balancing act for the FDA. It is caught between pressure to be more proactive against a rapidly changing virus and the risk that acting too quickly may deter families already on the fence about vaccinating their children.

Pfizer aims to give children as young as 6 months shots that contain one-tenth of the dose given to adults — two shots three weeks apart followed by a third at least two months later.

That’s a smaller dose than youngsters ages 5 to 11 receive, a third of the adult dose.

Vaccination rates have been lower among children than in other age groups. As of last week, just 22% of kids ages 5 to 11 and just over half of 12- to 17-year-olds were fully vaccinated, according to the American Academy of Pediatrics. Nearly three-quarters of adults are fully vaccinated.

A Kaiser Family Foundation poll taken last month found just 3 in 10 parents of children under 5 would get their youngster vaccinated as soon as shots were authorized, while about a quarter said they definitely would not.

Dr. Moira Szilagyi, the pediatricians group’s president, recognized parental frustration but said in a statement that doctors were committed to “a careful, robust and transparent process to evaluate the evidence.”

Dr. Natasha Burgert, a pediatrician in Overland Park, Kansas, said, “We’re just gutted. We need this protection for our kids.”

She said some families likely feel relieved “because they didn’t want to make that decision without good efficacy data. Other groups of parents are just crying out, ‘Give us a choice. Show us what you’ve got and let us make a choice. Let us have access to it.”’

Tags: COVID-19 InfectionsDr. Jesse GoodmanDr. Moira SzilagyiDr. Natasha BurgertFormer FDA Vaccine ChiefGeorgetown UniversityKaiser Family Foundation PollPfizerRachel PereraThe Food and Drug Administration
Previous Post

Lagos Bizman Accuses Police of Abducting Fiancée, Brothers, Demanding N3m

Next Post

IGP orders transfer of DCP Abba Kyari, four others to NDLEA for tempering with narcotic exhibits

Sharon O. Isaalah

Sharon O. Isaalah

Next Post
IGP orders transfer of DCP Abba Kyari, four others to NDLEA for tempering with narcotic exhibits

IGP orders transfer of DCP Abba Kyari, four others to NDLEA for tempering with narcotic exhibits

About The Trumpet

The Trumpet is a Nigerian based national news media, owned, trademarked and operated by Elomaz Communications Limited with headquarters in FCT-Abuja and regional offices in Lagos and Delta States

Follow Us

Resources

  • Home
  • News
    • Breaking News
    • Headlines
    • Metro
    • Health
  • Politics
  • Business
    • Ecommerce
    • Economy
    • Start-up
  • Entertainment
  • Sports
  • Opinion
    • Religion
    • Columnists
    • Contributors
    • Editorial
  • Global
    • Climate
    • Culture
    • Tourism
    • Technology
    • Weather
    • Social Media
  • e-Edition

Recent News

Nigeria Police Trust Fund

Senate approves extension of Nigeria Police Trust Fund to boost training, security operations

June 24, 2025
Delta Police

Delta Police arrest native doctor with pump-action guns, cutlass

June 24, 2025
  • Cookie Policy
  • Disclaimer
  • Contact us
  • About Us
  • Cookie Policy
  • Disclaimer
  • Contact us
  • About Us

© 2025 The Trumpet News Papers - Developed by VIS Nigeria.

No Result
View All Result
  • Home
  • News
    • Breaking News
    • Headlines
    • Metro
    • Health
  • Politics
  • Business
    • Ecommerce
    • Economy
    • Start-up
  • Entertainment
  • Sports
  • Opinion
    • Religion
    • Columnists
    • Contributors
    • Editorial
  • Global
    • Climate
    • Culture
    • Tourism
    • Technology
    • Weather
    • Social Media
  • e-Edition

© 2025 The Trumpet News Papers - Developed by VIS Nigeria.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Go to mobile version
Verified by MonsterInsights